Clinical Trials
14
Active:1
Completed:7
Trial Phases
5 Phases
Early Phase 1:1
Phase 1:2
Phase 2:5
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Phase 2
5 (38.5%)Phase 3
3 (23.1%)Not Applicable
2 (15.4%)Phase 1
2 (15.4%)Early Phase 1
1 (7.7%)Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
Not Applicable
Not yet recruiting
- Conditions
- Prostate CancerProstate Cancer (Diagnosis)High-risk Prostate CancerLocalized Prostate CarcinomaVery High Risk Prostate Carcinoma
- Interventions
- Drug: 177 Lutetium Prostate-Specific Membrane Antigen 617Drug: Actinium-225 Prostate-Specific Membrane Antigen 617Procedure: Non-investigational, ProstatectomyProcedure: Prostate Tissue CollectionProcedure: Single-photon emission computed tomography (SPECT)/Computerized tomography (CT)Procedure: Blood Sample Collection
- First Posted Date
- 2025-07-08
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Thomas Hope
- Target Recruit Count
- 45
- Registration Number
- NCT07054346
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Imaging of Solid Tumors Using DLL3 SPECT
Not Applicable
Not yet recruiting
- Conditions
- Solid Tumor CancerCastration Resistant Prostate Cancer (CRPC)Neuroendocrine (NE) TumorsCastration Resistant Prostate Cancer
- Interventions
- Drug: 111In-ABD147Procedure: Single-photon emission computed tomography (SPECT)/Computerized tomography (CT)
- First Posted Date
- 2025-07-07
- Last Posted Date
- 2025-07-07
- Lead Sponsor
- Thomas Hope
- Target Recruit Count
- 45
- Registration Number
- NCT07052760
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
Phase 2
Not yet recruiting
- Conditions
- Thyroid Cancer
- Interventions
- Drug: Iodine-124Procedure: Positron Emission Tomography (PET)/Computerized tomography (CT)
- First Posted Date
- 2025-05-07
- Last Posted Date
- 2025-07-01
- Lead Sponsor
- Thomas Hope
- Target Recruit Count
- 58
- Registration Number
- NCT06961084
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
Recruiting
- Conditions
- Intracranial Neoplasm
- Interventions
- Drug: Fluorethyltyrosine (18-F)Procedure: Positron Emission Tomography (PET)
- First Posted Date
- 2024-06-25
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Thomas Hope
- Target Recruit Count
- 199
- Registration Number
- NCT06474533
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286
Phase 1
Completed
- Conditions
- Liver FibrosisPulmonary FibrosisMyocardial Fibrosis
- Interventions
- Procedure: Positron Emission Tomography (PET)
- First Posted Date
- 2022-01-06
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Thomas Hope
- Target Recruit Count
- 16
- Registration Number
- NCT05180162
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
- Prev
- 1
- 2
- 3
- Next
News
No news found